New York S 300: Designates Xylazine as a schedule III depressant controlled substance

Status: REFERRED TO HEALTH (as of 2018-01-03)

State: New York · Session: 2017-2018 · Bill: S 300

Sponsors: MURPHY, AKSHAR, AMEDORE, BROOKS, CROCI, HELMING, MARCHIONE, O'MARA, ORTT, PHILLIPS, ROBACH, SERINO

View New York S 300 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.